Načítá se...
Increased assessment of HER2 in metastatic gastroesophageal cancer patients: a nationwide population-based cohort study
BACKGROUND: Addition of trastuzumab to first-line palliative chemotherapy in gastroesophageal cancer patients with HER2 overexpression has shown to improve survival. Real-world data on HER2 assessment and administration of trastuzumab are lacking. The aim of this study was to assess HER2 testing, tr...
Uloženo v:
| Vydáno v: | Gastric Cancer |
|---|---|
| Hlavní autoři: | , , , , , , , , , , |
| Médium: | Artigo |
| Jazyk: | Inglês |
| Vydáno: |
Springer Singapore
2020
|
| Témata: | |
| On-line přístup: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7305095/ https://ncbi.nlm.nih.gov/pubmed/31927675 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1007/s10120-020-01039-7 |
| Tagy: |
Přidat tag
Žádné tagy, Buďte první, kdo otaguje tento záznam!
|